HA-Pep-DTX

General Information


DRACP ID  DRACP06053

Peptide Name   HA-Pep-DTX

Sequence  CIELLQARX

Sequence Length  9

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Targeted peptide conjugates



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  HA, Hyaluronic acid

C-terminal Modification  Free

Other Modification  X=DTX, Docetaxel

Chiral  L



Physicochemical Information


Formula  C40H70N12O11S

Absent amino acids  DFGHKMNPSTVWY

Common amino acids  L

Mass  118002

Pl  6.23

Basic residues  1

Acidic residues  1

Hydrophobic residues  4

Net charge  0

Boman Index  -942

Hydrophobicity  54.44

Aliphatic Index  141.11

Half Life 
  /

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID CN113171342A

Patent Title  Tumor targeting nano-micelle based on hyaluronic acid as well as preparation and application of tumor targeting nano-micelle

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.